Nintedanib & Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF) in King Abdulaziz Medical City (KAMC), Riyadh - Real Life Data

被引：0
|
作者：
Khan, A. M. [1 ]
Al-Jahdali, H. H. [2 ]
Alharbi, A. S. [3 ]
Rajendram, R. [1 ]
Obaidi, M. [1 ]
Alghamdi, B. [1 ]
Hassan, I. [1 ]
机构：
[1] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Pulmonol Div, Med, Riyadh, Saudi Arabia
[2] King Fahad Natl Guard Hosp, Riyadh, Saudi Arabia
[3] King Abdul Aziz Med City, Natl Guards Hlth Affairs, Pulmonolgy, Med, Riyadh, Saudi Arabia
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1917
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [32] Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study
    Harari, S.
    Caminati, A.
    Albera, C.
    Vancheri, C.
    Poletti, V.
    Pesci, A.
    Luppi, F.
    Saltini, C.
    Agostini, C.
    Bargagli, E.
    Sebastiani, A.
    Sanduzzi, A.
    Giunta, V.
    Della Porta, R.
    Bandelli, G. P.
    Puglisi, S.
    Tomassetti, S.
    Biffi, A.
    Cerri, S.
    Mari, A.
    Cinetto, F.
    Tirelli, F.
    Farinelli, G.
    Bocchino, M.
    Specchia, C.
    Confalonieri, M.
    RESPIRATORY MEDICINE, 2015, 109 (07) : 904 - 913
  • [33] Analysis of Effectiveness of Pirfenidone in Subgroups of Idiopathic Pulmonary Fibrosis Based on Real World Data from European IPF Registry
    Krauss, E.
    Drakopanagiotakis, F.
    Costabel, U.
    Nieto Barbero, M.
    Mueller, V.
    Bonniaud, P.
    Vancheri, C.
    Wells, A. U.
    Vasakova, M.
    Pesci, A.
    Klepetko, W.
    Seeger, W.
    Crestani, B.
    Guenther, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [34] Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF)
    Fisher, Mark
    Maher, Toby M.
    Nathan, Steven D.
    Hill, Christian
    Marshall, Jade
    Dejonckheere, Fred
    Thuresson, Per-Olof
    Mathew, Nitya
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [35] Nintedanib for idiopathic pulmonary fibrosis (IPF): Data from the German compassionate use program (CUP)
    Bonella, Francesco
    Kreuter, Michael
    Hagmeyer, Lars
    Neurohr, Claus
    Keller, Claus
    Kohlhaufl, Martin J.
    Mueller-Quernheim, Joachim
    Milger, Katrin
    Prasse, Antje
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [36] Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life Study
    Aycicek, Olcay
    Keskin, Serra
    Haciosmanoglu, Muhammed
    Oztuna, Funda
    Bulbul, Yilmaz
    Ozlu, Tevfik
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [37] Nebulised pirfenidone in non-idiopathic pulmonary fibrosis (IPF) progressive pulmonary fibrosis (PPF): first look at FVC data
    West, Alex
    Lawrence, Alexandra
    Bao, Hao
    Nair, Deepthi
    Thompson, Courtney
    Woodhead, Felix
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [38] SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): LONG-TERM GLOBAL PHARMACOVIGILANCE DATA
    Lasky, Joseph
    Criner, Gerard
    Lazarus, Howard
    Kohlbrenner, Veronika
    Bender, Shaun
    Richeldi, Luca
    CHEST, 2019, 156 (04) : 1011A - 1012A
  • [39] Antifibrotic treatment in patients with Idiopathic pulmonary fibrosis (IPF): Real life data from a Swedish registry
    Carlson, Lisa
    Kalafatis, Dimitrios
    Pesonen, Ida
    Magnusson, Jesper
    Skold, Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [40] POOLED ANALYSIS OF MORTALITY DATA FROM THE TOMORROW AND INPULSIS TRIALS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Corte, T.
    Richeldi, L.
    Kirsten, A.
    Roman, J.
    Le Maulf, F.
    Hallmann, C.
    Stowasser, S.
    Lasky, J.
    RESPIROLOGY, 2015, 20 : 87 - 87
12345